These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38124425)

  • 1. Alternatives assessment: An analysis on progress and future needs for research and practice.
    Bechu AM; Roy MA; Jacobs M; Tickner JA
    Integr Environ Assess Manag; 2023 Dec; ():. PubMed ID: 38124425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of alternatives assessment in chemicals management policies: Needs for greater impact.
    Rudisill C; Jacobs M; Roy M; Brown L; Eaton R; Malloy T; Davies H; Tickner J
    Integr Environ Assess Manag; 2024 Jul; 20(4):1035-1045. PubMed ID: 37658263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancing alternatives assessment for safer chemical substitution: A research and practice agenda.
    Tickner J; Jacobs M; Malloy T; Buck T; Stone A; Blake A; Edwards S
    Integr Environ Assess Manag; 2019 Nov; 15(6):855-866. PubMed ID: 30117284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative approach to comparative exposure in alternatives assessment.
    Greggs W; Burns T; Egeghy P; Embry MR; Fantke P; Gaborek B; Heine L; Jolliet O; Lee C; Muir D; Plotzke K; Rinkevich J; Sunger N; Tanir JY; Whittaker M
    Integr Environ Assess Manag; 2019 Nov; 15(6):880-894. PubMed ID: 29917303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Informed substitution of hazardous chemicals through the lens of California's Safer Consumer Products Alternatives Analysis: Best practices, challenges, and opportunities.
    Grant KA; Nakayama Wong L; Meng Q; Lee H; Phelps D; Davis S; Salinas M; Luan T; Zhou X
    Integr Environ Assess Manag; 2022 Jun; 18(4):1007-1019. PubMed ID: 34590786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quantitative screening-level approach to incorporate chemical exposure and risk into alternative assessment evaluations.
    Arnold SM; Greggs B; Goyak KO; Landenberger BD; Mason AM; Howard B; Zaleski RT
    Integr Environ Assess Manag; 2017 Nov; 13(6):1007-1022. PubMed ID: 28294522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons from the 2018 International Symposium on Alternatives Assessment: Advances and Reflections on Practice and Ongoing Needs to Build the Field.
    Tickner J; Simon R; Jacobs M; Rudisill C; Tanir J; Heine L; Spencer P; Fantke P; Malloy T; Edwards S; Zhou X
    Integr Environ Assess Manag; 2019 Nov; 15(6):909-916. PubMed ID: 31535774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternatives Assessment Frameworks: Research Needs for the Informed Substitution of Hazardous Chemicals.
    Jacobs MM; Malloy TF; Tickner JA; Edwards S
    Environ Health Perspect; 2016 Mar; 124(3):265-80. PubMed ID: 26339778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frameworks for screening and risk management of chemicals and advanced materials: A critical review.
    Moore DW; Ruffle B; McQueen A; Thakali S; Edwards D
    Integr Environ Assess Manag; 2023 Sep; 19(5):1192-1206. PubMed ID: 35112493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancing the weight of evidence approach to enable chemical environmental risk assessment for decision-making and achieving protection goals.
    Lee KC; Guiney PD; Menzie CA; Belanger SE
    Integr Environ Assess Manag; 2023 Sep; 19(5):1188-1191. PubMed ID: 37421247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The applicability of chemical alternatives assessment for engineered nanomaterials.
    Hjorth R; Hansen SF; Jacobs M; Tickner J; Ellenbecker M; Baun A
    Integr Environ Assess Manag; 2017 Jan; 13(1):177-187. PubMed ID: 26887668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative evaluation of five hazard screening tools.
    Panko JM; Hitchcock K; Fung M; Spencer PJ; Kingsbury T; Mason AM
    Integr Environ Assess Manag; 2017 Jan; 13(1):139-154. PubMed ID: 26777143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the sustainable use of chemicals on a level playing field.
    Everard M
    Integr Environ Assess Manag; 2023 Jul; 19(4):1131-1146. PubMed ID: 36519960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When Are Adverse Outcome Pathways and Associated Assays "Fit for Purpose" for Regulatory Decision-Making and Management of Chemicals?
    Coady K; Browne P; Embry M; Hill T; Leinala E; Steeger T; Maślankiewicz L; Hutchinson T
    Integr Environ Assess Manag; 2019 Jul; 15(4):633-647. PubMed ID: 30908812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approach to weight-of-evidence assessment of ecotoxicological effects in regulatory decision-making.
    Hall AT; Belanger SE; Guiney PD; Galay-Burgos M; Maack G; Stubblefield W; Martin O
    Integr Environ Assess Manag; 2017 Jul; 13(4):573-579. PubMed ID: 28383801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technology acceptance of the PFAS Guide among European companies.
    Zheng G; Onencan AM
    Integr Environ Assess Manag; 2024 Jun; ():. PubMed ID: 38860629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward sustainable environmental quality: Identifying priority research questions for Latin America.
    Furley TH; Brodeur J; Silva de Assis HC; Carriquiriborde P; Chagas KR; Corrales J; Denadai M; Fuchs J; Mascarenhas R; Miglioranza KS; Miguez Caramés DM; Navas JM; Nugegoda D; Planes E; Rodriguez-Jorquera IA; Orozco-Medina M; Boxall AB; Rudd MA; Brooks BW
    Integr Environ Assess Manag; 2018 May; 14(3):344-357. PubMed ID: 29469193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.